Axid and Fluid retention - a phase IV clinical study of FDA data

Summary:

Fluid retention is reported as a side effect among people who take Axid (nizatidine), especially for people who are female, 40-49 old, also take Lasix, and have Atherosclerosis.

The phase IV clinical study analyzes which people have Fluid retention when taking Axid. It is created by eHealthMe based on reports of 2,951 people who have side effects when taking Axid from the FDA, and is updated regularly.

What is Axid?

Axid has active ingredients of nizatidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 2,980 Axid users. Check the latest studies of Axid.

What is Fluid retention?

Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 1,698 drugs and 2,449 conditions by eHealthMe. Check the latest studies of Fluid retention.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

2,951 people reported to have side effects when taking Axid.
Among them, 13 people (0.44%) have Fluid retention.

Among these 13 people:

What is the gender of people who have Fluid retention when taking Axid? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Fluid retention when taking Axid? *

What are other drugs people take besides Axid? *

What are other side effects people have besides Fluid retention? *

Cardiac Failure Congestive: 5 people, 38.46%
Oedema Peripheral (superficial swelling): 5 people, 38.46%
Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Chest Pain: 5 people, 38.46%
Dyspnea (difficult or laboured breathing): 4 people, 30.77%
Weight Increased: 3 people, 23.08%
Heart Attack: 3 people, 23.08%
Fever: 3 people, 23.08%
Fatigue (feeling of tiredness): 3 people, 23.08%
Cellulitis (infection under the skin): 3 people, 23.08%

What are the existing conditions these people have? *

Thyroid Diseases: 2 people, 15.38%
High Blood Pressure: 2 people, 15.38%
Diabetes: 2 people, 15.38%
Atherosclerosis (disorder of the arteries): 2 people, 15.38%
Type 2 Diabetes: 1 person, 7.69%
Renal Cell Carcinoma (a kidney cancer): 1 person, 7.69%
Pulmonary Congestion (congestion in the lungs): 1 person, 7.69%
Pain: 1 person, 7.69%
Impaired Gastric Emptying: 1 person, 7.69%
Haematological Malignancy (cancer that affect blood, bone marrow, and lymph nodes): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Axid and have Fluid retention?

- Check whether Fluid retention is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Axid:

Axid (2,980 reports)

Fluid retention treatments and more:

Fluid retention (79,661 reports)

Browse all side effects of Axid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fluid retention:

Fluid retention (1,698 drugs)

Browse all the conditions that are associated with Fluid retention:

Fluid retention (2,449 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nizatidine (the active ingredients of Axid) and Axid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.